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Human herpesvirus-6 as a possible cause of encephalitis and hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation Leukemia (2002) 16, 958-959. DOI: 10.1038/sj/leu/2402403 TO THE EDITOR Human herpesvirus 6 (HHV-6) is an increasingly recognized pathogen in hematopoietic stem cell transplantation (HSCT) recipients 1 and has recently been reported to cause encephalitis. To date, 13 cases of HHV-6 encephalitis after HSCT have been reported. [2] [3] [4] HHV-6 has been found to have greater susceptibility to ganciclovir and foscarnet. Foscarnet, however, is preferred because of a higher concentration in the cerebrospinal fluid (CSF) and only two cases of encephalitis were treated with just ganciclovir in previous reports. 2 We experienced two cases of HHV-6 encephalitis after allogeneic HSCT and their characteristics are summarized in Table 1 . One patient (case 1) began to show agitation on day +21, with signal abnormalities in radiologic study (Figure 1a) , and a cellular hematuria developed over the following days. The other patient (case 2), 1 month after transplant, presented with fever, generalized skin rash and disorientation. His mental status finally decreased to a drowsy state on day +51. The possibilities of drug toxicity and metabolic influences were ruled out in both cases. Treatment with i.v. ganciclovir (5 mg/kg every 12 h) commenced when the PCR for HHV-6 variant B from the CSF, which was tested elsewhere, 5 was positive (Figure 1b) . The DNA of HHV-6 variant A, HSV type 1 and 2, EBV, and CMV was not detected from the CSF. The patients' neurological symptoms were resolved with 3 weeks of ganciclovir therapy, and clinical improvements accompanied with a regression of the signal abnormalities on MRI (case 1) and conversion of PCR to negative result in the CSF and serum samples.
Further analyses were performed to reveal the cause of hematuria in case 1. PCR analysis for the HHV-6 variant B from the urine samples showed positive results. No bacterial, fungal or mycobacterial pathogens were detected in the urine samples. DNA PCR 6 for BKV and JCV and immunofluorescence staining with anti-adenovirus antibody (mouse monoclonal antibody, Chemicon International, Temecula, CA, USA) from the urine was also negative. Interestingly, an improvement in CNS symptoms also accompanied with a gradual decrease and final disappearance of the hematuria and PCR negativity for HHV-6 in the urine samples.
As HHV-6 has been found in the renal tubular endothelial cells and kidney, 7 these clinical data imply a role of HHV-6 in hematuria that develops after HSCT. This suggests that HHV-6 is associated with urinary tract damage, but it cannot be considered as conclusive evidence because sporadic PCR positivity for HHV-6 in the urine was found in 9% of patients after HSCT. 8 In conclusion, these cases stress the emerging role of HHV-6 in encephalitis after HSCT and usefulness of ganciclovir therapy. A link between a HHV-6 infection and a hemorrhagic cystitis has never been described elsewhere and still remains uncertain. Further research should be undertaken.
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Catholic Hematopoietic CML, chronic myelogenous leukemia; CP, chronic phase; AML, acute myeloid leukemia; CR, complete remission; CMV, cytomeglovirus; GVHD, graft-versus-host disease; NS, not specific; CT, computed tomography; MRI, magnetic resonance imaging.
Figure 1
Patient 1, MRI of the brain at the time of diagnosis (a) showed high signal intensities in the subcortical white matter around the right posterior frontal operacular region and the right temporal lobe. Analysis of the multiplex PCR products of patients by agarose gel electrophoresis after staining with ethidium bromide (b). Lane M, size marker (100 bp ladder). HHV-6-variant B DNA detected in the CSF at the time of diagnosis (1) was negative 3 weeks after ganciclovir therapy (2) as is the same in the urine (3 and 4) . Lanes 5, 6 and 7, positive control for EBV (5), CMV (6), HHV-6B (7).
